Recent

% | $
Quotes you view appear here for quick access.

Petróleo Brasileiro S.A. - Petrobras Message Board

larry_dalliapoulos 2 posts  |  Last Activity: 7 hours ago Member since: Mar 23, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • larry_dalliapoulos larry_dalliapoulos 7 hours ago Flag

    Thanks slug and computer. Viva la Mannkind!

  • larry_dalliapoulos by larry_dalliapoulos 15 hours ago Flag

    When was the last time Sanofi launched a first-in-class product that represents a paradigm shift? If it has been a while, perhaps they are too big and stuck in their mode of pushing products by competing on price, margins, volume, etc. What I fear is needed here is a "Delta Force" of change, not a large marching army that can only follow the present course.

    Are there any other big or medium pharmas that are experts and penetrating markets with paradigm shifting products? Is there a boutique pharma sales/consulting firm that can tell Sanofi how they need to attack this differently? This is not Lantus, Toujeo, or anything else they hock, so they can't follow the same strategy they would for those products. Dinners are fine, but it just seems very old school and your reach is limited. Why not a webcast that a physician registers for and received something in compensation for viewing the presentation and answering a short survey afterward. Sometimes when you are the biggest boy on the block, you keep doing what you have been doing because it has worked and you may feel your weight will get you your way.

    I am not in Marketing or Pharma, so perhaps Sanofi knows all about how to market this product the right way. At this point in time however, I am not seeing it yet.

    To the poster who said something on another thread to the effect of "you don't change horses mid-stream", your point is understood. However, sometimes you do need to change course before it's too late. I don't like to reward non-performance. If we haven't gotten a strong foothold in this market by the next shareholder vote, a change will be made, if not sooner. Honestly, I don't know why Sanofi is doing (or not doing) things the way they are. I sure hope they explain, and I sure hope Mannkind management is asking these questions in closed-door meetings.

PBR
7.07+0.48(+7.28%)4:00 PMEDT